The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
6
- 1
Higham, Paul Grant
Born in December 1962Individual (1 offspring)Officer
2024-06-07 ~ nowOF - Director → CIF 0 - 2
Wigginton, Jon, Dr
Born in October 1961Individual (1 offspring)Officer 2025-07-14 ~ nowOF - Director → CIF 0 - 3
Harris, Samantha Ann
Individual (3 offsprings)Officer 2022-06-15 ~ nowOF - Secretary → CIF 0 - 4
Mccarthy, Thomas David
Born in June 1967Individual (11 offsprings)Officer 2017-02-27 ~ nowOF - Director → CIF 0 - 5
Nave, Christopher Dean
Born in December 1974Individual (2 offsprings)Officer 2019-09-09 ~ nowOF - Director → CIF 0 - 6
Ahrens, Brenton Karl
Born in March 1963Individual (3 offsprings)Officer 2019-08-28 ~ nowOF - Director → CIF 0
Ceased
6
- 1
Sidhu, Someit Singh
Company Director born in May 1989Individual (12 offsprings)Officer 2017-02-27 ~ 2019-08-28OF - Director → CIF 0Dr Someit Singh Sidhu
Born in May 1989Individual (12 offsprings)Person with significant control 2017-02-27 ~ 2018-10-29PE - Has significant influence or control → CIF 0 - 2
Hughes, Stuart Wynn, Dr
Ceo born in November 1970Individual (1 offspring)Officer 2019-11-22 ~ 2024-06-07OF - Director → CIF 0 - 3
Unitt, John Francis, Dr
Director Of Bioscience born in September 1963IndividualOfficer 2018-11-28 ~ 2019-08-28OF - Director → CIF 0 - 4
Guenot, Jeanmarie, Dr
Ceo born in July 1964IndividualOfficer 2022-08-26 ~ 2025-03-06OF - Director → CIF 0 - 5
Mccarthy, Kirsty Ann
Individual (6 offsprings)Officer 2017-02-27 ~ 2022-06-15OF - Secretary → CIF 0 - 6
2765, Sand Hill Road, Menlo Park, California, United StatesCorporatePerson with significant control2019-08-28 ~ 2019-08-28PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Company in focus
PATHIOS THERAPEUTICS LIMITED
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
72024-01-01 ~ 2024-12-31
82023-01-01 ~ 2023-12-31
Property, Plant & Equipment
20,560 GBP2024-12-31
42,009 GBP2023-12-31
Fixed Assets - Investments
761,572 GBP2024-12-31
85 GBP2023-12-31
Fixed Assets
782,132 GBP2024-12-31
42,094 GBP2023-12-31
Debtors
Current
1,493,010 GBP2024-12-31
1,641,557 GBP2023-12-31
Cash at bank and in hand
3,250,384 GBP2024-12-31
2,784,025 GBP2023-12-31
Current Assets
4,743,394 GBP2024-12-31
4,425,582 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-677,300 GBP2024-12-31
-697,281 GBP2023-12-31
Net Current Assets/Liabilities
4,066,094 GBP2024-12-31
3,728,301 GBP2023-12-31
Net Assets/Liabilities
4,848,226 GBP2024-12-31
3,770,395 GBP2023-12-31
Equity
Called up share capital
352 GBP2024-12-31
298 GBP2023-12-31
298 GBP2023-01-01
Share premium
33,584,645 GBP2024-12-31
25,766,682 GBP2023-12-31
25,766,682 GBP2023-01-01
Capital redemption reserve
1 GBP2024-12-31
1 GBP2023-12-31
1 GBP2023-01-01
Retained earnings (accumulated losses)
-28,736,772 GBP2024-12-31
-21,996,586 GBP2023-12-31
-15,925,512 GBP2023-01-01
Equity
4,848,226 GBP2024-12-31
3,770,395 GBP2023-12-31
9,841,469 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
-6,740,186 GBP2024-01-01 ~ 2024-12-31
-6,071,074 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-6,740,186 GBP2024-01-01 ~ 2024-12-31
-6,071,074 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
Called up share capital
54 GBP2024-01-01 ~ 2024-12-31
Issue of Equity Instruments
7,818,017 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Gross Cost
Office equipment
46,983 GBP2024-12-31
46,983 GBP2023-12-31
Computers
49,673 GBP2024-12-31
38,837 GBP2023-12-31
Other
77,556 GBP2024-12-31
77,556 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
174,212 GBP2024-12-31
163,376 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
33,545 GBP2023-12-31
Computers
35,004 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
121,367 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
7,133 GBP2024-01-01 ~ 2024-12-31
Owned/Freehold
32,285 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
42,388 GBP2024-12-31
Computers
42,137 GBP2024-12-31
Other
69,127 GBP2024-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
153,652 GBP2024-12-31
Property, Plant & Equipment
Office equipment
4,595 GBP2024-12-31
13,438 GBP2023-12-31
Computers
7,536 GBP2024-12-31
3,833 GBP2023-12-31
Other
8,429 GBP2024-12-31
24,738 GBP2023-12-31
Other Debtors
Current
248,833 GBP2024-12-31
323,654 GBP2023-12-31
Prepayments/Accrued Income
Current
147,567 GBP2024-12-31
52,963 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
1,096,610 GBP2024-12-31
1,264,940 GBP2023-12-31
Trade Creditors/Trade Payables
Current
391,629 GBP2024-12-31
486,021 GBP2023-12-31
Amounts owed to group undertakings
Current
85 GBP2024-12-31
85 GBP2023-12-31
Taxation/Social Security Payable
Current
94,313 GBP2024-12-31
93,619 GBP2023-12-31
Other Creditors
Current
10,847 GBP2024-12-31
5,219 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
180,426 GBP2024-12-31
112,337 GBP2023-12-31
Creditors
Current
677,300 GBP2024-12-31
697,281 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
520,098 shares2024-12-31
513,193 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.00012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
2,996,099 shares2024-12-31
2,465,628 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0.00012024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
530,471 shares2024-12-31
Par Value of Share
Class 3 ordinary share
0.00012024-01-01 ~ 2024-12-31
Related profiles found in government register
- Registered number 10641754
PATHIOS THERAPEUTICS LIMITED
Info99 Park Drive, Milton, Abingdon OX14 4RYPRIVATE LIMITED COMPANY incorporated on 2017-02-27 (8 years 10 months). The company status is Active.The last date of confirmation statement was made at 2025-02-26CIF 0 PATHIOS THERAPEUTICS LIMITED
SRegistered number 1064175499, Park Drive, Milton, Abingdon, England, OX14 4RYPrivate Company Limited By Shares in Uk Register Of Companies, United KingdomCIF 1
Offspring entities and appointments
Active
1
- 99 Park Drive, Milton, Abingdon, EnglandActive Corporate (2 parents)Equity (Company account)1 GBP2024-12-31Person with significant control 2023-02-27 ~ nowCIF 1 - Ownership of voting rights - 75% or more → OECIF 1 - Ownership of shares – 75% or more → OECIF 1 - Right to appoint or remove directors → OE
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.